Opportunity ID: 220074

General Information

Document Type:: Grants Notice
Funding Opportunity Number:: PAR-13-113
Funding Opportunity Title:: Improvement of Animal Models for Stem Cell-Based Regenerative Medicine (R24)
Opportunity Category:: Discretionary
Opportunity Category Explanation::
Funding Instrument Type::
Category of Funding Activity:: Health
Category Explanation::
Expected Number of Awards::
Assistance Listings Number(s):: 93.351 — Research Infrastructure Programs
Cost Sharing or Matching Requirement:: No
Version:: Synopsis 2
Posted Date:: Feb 11, 2013
Last Updated Date:: Jul 03, 2013
Original Closing Date for Applications:: May 07, 2016
Current Closing Date for Applications:: Jul 03, 2013
Archive Date:: Aug 03, 2013
Estimated Total Program Funding::
Award Ceiling:: $
Award Floor:: $

Eligibility

Eligible Applicants:: State governments
Additional Information on Eligibility:: Other Eligible Applicants include the following:
Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U.S. Organizations are noteligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are not allowed.

Additional Information

Agency Name:: National Institutes of Health
Description:: This FOA encourages Resource-Related Research Project Grant (R24) applications from institutions and organizations proposing research aimed at characterizing animal stem cells and improving existing and creating new animal models for human disease conditions. The intent of this initiative is to facilitate the use of stem cell-based therapies for regenerative medicine. The initiative focuses on the following areas: 1) comparative analysis of animal and human stem cells to provide information for selection of the most predictive and informative model systems; 2) development of new technologies for stem cell characterization and transplantation; and 3) improvement of animal disease models for stem cell-based therapeutic applications.
Link to Additional Information::
Grantor Contact Information:: If you have difficulty accessing the full announcement electronically, please contact:

Version History

Version Modification Description Updated Date
Synopsis 2 This funding opportunity is being closed and archived, and has been reissued as PAR-13-252. Jul 03, 2013
Synopsis 1

Package Status

Package No: 1

Related Documents